FECAL LACTOFERRIN IN NON-INVASIVE DIAGNOSTIC OF COLORECTAL CANCER
https://doi.org/10.51523/2708-6011.2010-7-2-30
Abstract
Possibilities of revealing of malignant tumours of a colon had been studied at 48 patients with colorectal cancer, 47 with irritable bowel syndrome and 25 healthy volunteers by the complex comparative analysis. It is established, that fecal lactoferrin had the highest diagnostic importance. (AUC: 0,95; 95 % CI: 0,89-0,98). The marker possessed sensitivity - 79,17 % (95 % CI: 65,00-89,50), specificity - 90,14 % (95 % CI: 80,70-95,90).
References
1. Boyle, P. Epidemiology of colorectal cancer / Р. Boyle, M. E. Leon // Brit. Med. Bull. - 2002. - № 64. - P. 1-25.
2. Epidemiology and screening of colorectal cancer / J. Faivre, [et al.] // Best Pract. Res. Clin.Gastroenterol. - 2002. - № 16. - P. 187-199.
3. Papapolychroniadis, C. Environmental and other risk factors for colorectal carcinogenesis / C. Papapolychroniadis // Tech. Coloproctol. - 2004. - № 8. - P. 7-9.
4. Скрининг колоректального рака (литературный обзор) / Е. И. Михайлова [и др.] // Проблемы здоровья и экологии. - 2005. - № 2. - С. 79-82.
5. Dubrow, R. Fecal lysozyme: An unreliable marker for colorectal cancer / R. Dubrow, C. S. Kim, А. К. Eldred // Am. J. Gastroenterol. - 1992. - № 87. - Р. 617-621.
6. ELISA for occult faecal albumin / Т. Nakayama [et al.] // Lancet. - 1987. - № 1. - Р. 1368-1369.
7. Dubrow, R. Fecal protein markers of colorectal cancer / R Dubrow, L. Yannielli // Am. J. Gastroenterol. - 1992. - № 87. - Р. 854-858
8. Haug, U. New stool tests for colorectal cancer screening: A systematic review focusing on performance characteristics and practicalness / U. Haug, H. Brenner // Int. J. Cancer. - 2005. - № 117. - Р. 169-176.
Review
For citations:
Filipenko N.V. FECAL LACTOFERRIN IN NON-INVASIVE DIAGNOSTIC OF COLORECTAL CANCER. Health and Ecology Issues. 2010;(2):143-148. (In Russ.) https://doi.org/10.51523/2708-6011.2010-7-2-30
Views: 226
Email this article 